MIAMI, FL / ACCESS Newswire / January 27, 2025 / In a move poised to redefine Brazil's global commodities trade, SMX (Security Matters) Ltd. and Ybyrá Capital S.A. are inching closer to finalizing a ...

Presentation Operator Good, everyone, and welcome to the Energy's 4th-Quarter 2024 Financial Results Conference Call. All ...

Coinbase Global Inc. (NASDAQ:COIN) remains a dominant player, offering a wide variety of cryptocurrencies ... or for omissions from the information in this document. 7) Any graphs, tables or other ...

D-Wave Quantum is expanding aggressively its customer base with new partnerships and a promising 3-month free trial for new customers. Learn more on QBTS stock here.

Peter began covering markets at Multex (Reuters) and has expanded his coverage to include investments, ethics, public policy ... stories behind the numbers, graphs, and financial models.

BofA Securities, Goldman Sachs & Co. LLC, Evercore ISI, Guggenheim Securities and Cantor acted as joint bookrunners for the offering.

Nuvectis intends to use the net proceeds from the offering to continue to advance the development programs of NXP800 and NXP900 or any future product candidate, hiring of additional personnel, capital ...

SailPoint, a leader in unified identity security for enterprises, today announced that it has launched the roadshow for its proposed initial public offering of 50,000,000 shares of its common ...

In addition, Akero intends to grant the underwriters a 30-day option to purchase up to an additional $45.0 million of shares of its common stock at the public offering price, less underwriting ...

All of the shares in the offering were sold by Immunome. J.P. Morgan, TD Cowen, Leerink Partners and Guggenheim Securities acted as joint book-running managers for the offering. Wedbush PacGrow ...

In connection with the proposed offering, Immunome expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of its common stock sold in the public offering.

The shares are being offered under a previously filed shelf registration statement with the SEC. Akero Therapeutics successfully priced an upsized public offering of 5,333,420 shares of common ...